Tags: Drug.

Vantictumab is a monoclonal antibody designed for the treatment of cancer.This drug was developed by OncoMed Pharmaceuticals Inc.

ATC prefix
none
CAS number
1345009-45-1

Loading...

This page contains content from the copyrighted Wikipedia article "Vantictumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.